Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 4 de 4
Filtrer
Plus de filtres











Base de données
Gamme d'année
1.
Ned Tijdschr Geneeskd ; 150(49): 2702, 2006 Dec 09.
Article de Néerlandais | MEDLINE | ID: mdl-17194006

RÉSUMÉ

A 50-year-old woman complained of nausea, diarrhoea, tiredness and dizziness five weeks after a visit to Egypt. She was deeply tanned with hyperpigmentation on the metacarpophalangeal joints, palm of hand creases and buccal mucosa, due to Addison's disease.


Sujet(s)
Maladie d'Addison/diagnostic , Anti-inflammatoires/usage thérapeutique , Hydrocortisone/usage thérapeutique , Hyperpigmentation/étiologie , Maladie d'Addison/traitement médicamenteux , Maladie d'Addison/anatomopathologie , Diagnostic différentiel , Femelle , Humains , Adulte d'âge moyen , Nausée/étiologie , Résultat thérapeutique , Perte de poids
2.
Neth Heart J ; 11(3): 123-128, 2003 Mar.
Article de Anglais | MEDLINE | ID: mdl-25696194

RÉSUMÉ

The typical dyslipidaemia in type 2 diabetes mellitus shows high levels of triglycerides, low levels of highdensity lipoprotein cholesterol (HDL-c) and small dense low-density lipoprotein (LDL) particles. In these patients low-dose atorvastatin (10 mg) results in a significant and relevant reduction in triglycerides and LDL-c. High-dose atorvastatin (80 mg) results in a better LDL-c reduction. The endothelial dysfunction is likely to be caused by factors related to insulin resistance and not by dyslipidaemia alone. The results from the DALI study (Diabetes Atorvastatin Lipid Intervention) on lipids and endothelial function are discussed, together with two invasive endothelial function studies in diabetics and hypertriglyceridaemic patients. The subgroup of diabetics in the large secondary prevention trials using statins are analysed with respect to total cholesterol lowering and death due to coronary heart disease and nonfatal myocardial infarction.

3.
J Intern Med ; 251(4): 301-6, 2002 Apr.
Article de Anglais | MEDLINE | ID: mdl-11952880

RÉSUMÉ

OBJECTIVE: Is the concept of primary and secondary cardiovascular prevention an old-fashioned concept that needs to be re-defined? DESIGN: Discussion paper. RESULTS: Cardiovascular prevention means reduction of absolute risk for cardiovascular disease (CVD), irrespective of clinical stage. CONCLUSION: For the calculation of an individual probability to develop CVD all factors that contribute to the risk must be taken into account, including previous CVD events.


Sujet(s)
Maladies cardiovasculaires/prévention et contrôle , Prévention primaire/méthodes , Adulte , Sujet âgé , Vieillissement , Maladies cardiovasculaires/étiologie , Enfant , Humains , Obésité/complications , Facteurs de risque , Fumer/effets indésirables
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE